Debucquoy, A.
153  Ergebnisse:
Personensuche X
?
 
?
2

OC-0510 MRI radiomics to predict tumour response in patient..:

Bulens, P. ; Couwenberg, A. ; Intven, M....
Radiotherapy and Oncology.  133 (2019)  - p. S265-S266 , 2019
 
?
3

Patient-Reported Functional Outcome of Patients with Rectal..:

Bulens, P. ; Debucquoy, A. ; Joye, I....
International Journal of Radiation Oncology*Biology*Physics.  105 (2019)  1 - p. S105 , 2019
 
?
4

EP-2308: Inhibition of lipogenesis: a promising approach to..:

Bulens, P. ; Debucquoy, A. ; Swinnen, J..
Radiotherapy and Oncology.  127 (2018)  - p. S1273-S1274 , 2018
 
?
5

PO-0977: Plasma lipidomics for predictive biomarker analysi..:

Bulens, P. ; Debucquoy, A. ; Bloch, K....
Radiotherapy and Oncology.  123 (2017)  - p. S540-S541 , 2017
 
?
 
?
7

Does Integrating Functional Imaging and Molecular Markers C..:

Joye, I. ; Debucquoy, A. ; Deroose, C.M....
International Journal of Radiation Oncology*Biology*Physics.  96 (2016)  2 - p. E171 , 2016
 
?
8

PV-0122: Clinical factors as a selection tool for organ-pre..:

Joye, I. ; Debucquoy, A. ; Fieuws, S....
Radiotherapy and Oncology.  119 (2016)  - p. S55-S56 , 2016
 
?
9

EP-2055: Fibro-inflammatory circulating proteins as biomark..:

Bulens, P. ; Debucquoy, A. ; Joye, I....
Radiotherapy and Oncology.  119 (2016)  - p. S969-S970 , 2016
 
?
10

EP-1282: Does blood glucose level normalisation improve PET..:

Joye, I. ; Debucquoy, A. ; Wolthuis, A....
Radiotherapy and Oncology.  119 (2016)  - p. S602-S603 , 2016
 
?
11

OC-0019: The role of functional imaging and molecular marke..:

Joye, I. ; Debucquoy, A. ; Deroose, C....
Radiotherapy and Oncology.  115 (2015)  - p. S10-S11 , 2015
 
?
 
?
14

Combining bevacizumab and chemoradiation in rectal cancer. ..:

Verstraete, M ; Debucquoy, A ; Dekervel, J...
British Journal of Cancer.  112 (2015)  8 - p. 1314-1325 , 2015
 
?
 
1-15